Latest news
SVN-015 Advances into Further NIDA-Funded Studies Following Encouraging Initial Screening - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 14:43:14 GMTSolvonis Therapeutics' SVN-015 Progresses to Advanced NIDA-Funded Preclinical Trials Following Positive Cardiac Ion-Channel Screening - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 06:00:09 GMTPromatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMT